More news
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (23)
- Nov (34)
- Dec (14)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Dr. Steven Gross offers an IDIBAPS Seminar about the role of lipid droplets on the organismal antibacterial response
Cells are highly structured, and this structure is created and maintained using the cytoskeleton in conjunction with molecular motors. Dr. Steven Gr1
Three IDIBAPS investigators discuss in a book the latest and most significant research in the field of epigenetics and lifestyle
NEJM includes a work with the participation of IDIBAPS among the 50 most relevant articles in the history of Diabetis
The New England Journal of Medicine (NEJM) has recently published a review titled “The Past 200 Years in Diabetes”. Although it is explained that Dia1
Spanish scientists decipher the first epigenomes of CLL
The study, published today in Nature Genetics, represents a new perspective on cancer research, integrating the results of the complete sequencing of1
IDIBAPS researchers discover how a new type of RNA is related with diabetes
Complex diseases such as diabetes are usually not caused by a single gene. These pathologies produced by a complex genetic equilibrium that is slowly1
Long-term use of inhaled corticosteroids reduces the incidence of pleural effusion in patients with community acquired pneumonia
HIVACAT has been licensed by the CSIC to develop a vaccine against HIV
The HIVACAT program for the development of this vaccine today announced the obtention of a license to advance in the development of a possible vaccin1
Thaís Armangué was the best rated candidate in the 2012 PFIS call
The Ayudas predoctorales de Formación en Investigación en Salud (PFIS) is one of the main funding resources of the Institute of Health Carlos III, Mi1